HMGB3 and nasopharyngeal carcinoma: By conducting qRT-PCR analysis of 30 pairs of clinical specimens from nasopharyngeal carcinoma and non-tumor patients, the elevated expression of HMGB3 in nasopharyngeal carcinoma was confirmed (Fig. 3B).